These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 27275637)
1. [The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma]. Paksi M; Demeter J; Szabó P Magy Onkol; 2016 Jun; 60(2):108-17. PubMed ID: 27275637 [TBL] [Abstract][Full Text] [Related]
2. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378 [TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma. Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review. Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of diffuse large B-cell lymphoma patients with 64-slice multidetector computed tomography versus Gómez León N; Vega G; Rodríguez-Vigil Junco B; Suevos Ballesteros C Med Clin (Barc); 2018 Oct; 151(7):255-264. PubMed ID: 29705152 [TBL] [Abstract][Full Text] [Related]
8. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [TBL] [Abstract][Full Text] [Related]
9. Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study. Rybka J; Małkowski B; Olejniczak M; Chmielowska E; Sokołowska E; Kuliczkowski K; Wróbel T Adv Clin Exp Med; 2019 Aug; 28(8):1095-1099. PubMed ID: 31237123 [TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031 [TBL] [Abstract][Full Text] [Related]
12. [Research progress on 18F-FDG PET/CT in evaluating prognosis of patient with diffuse large B cell lymphoma]. Yang Y; Zhu HY; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):255-60. PubMed ID: 25687083 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma. Tateishi U; Tatsumi M; Terauchi T; Ando K; Niitsu N; Kim WS; Suh C; Ogura M; Tobinai K Cancer Sci; 2015 Feb; 106(2):186-93. PubMed ID: 25495273 [TBL] [Abstract][Full Text] [Related]
14. Integration of PET in DLBCL. Lewis KL; Trotman J Semin Hematol; 2023 Nov; 60(5):291-304. PubMed ID: 38326144 [TBL] [Abstract][Full Text] [Related]
15. An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Moskowitz CH; Zelenetz A; Schoder H J Natl Compr Canc Netw; 2010 Mar; 8(3):347-52. PubMed ID: 20202464 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742 [TBL] [Abstract][Full Text] [Related]
17. End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma. Kostakoglu L; Nowakowski GS PET Clin; 2019 Jul; 14(3):307-315. PubMed ID: 31084771 [TBL] [Abstract][Full Text] [Related]
18. Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful. Shah HJ; Keraliya AR; Jagannathan JP; Tirumani SH; Lele VR; DiPiro PJ Korean J Radiol; 2017; 18(1):54-70. PubMed ID: 28096718 [TBL] [Abstract][Full Text] [Related]
19. 2-deoxy-2-[ Withofs N; Bonnet C; Hustinx R PET Clin; 2024 Oct; 19(4):447-462. PubMed ID: 38945737 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]